Rare diseases
Investigational molecules
Locations
Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
HungaryBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
HungaryA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
HungaryA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
HungaryA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
HungaryA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
HungaryA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
HungaryStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
HungaryStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
HungaryA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
HungaryA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
HungaryPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
HungaryTell us about your condition – we search every trial in Europe and connect you with the right site.
